KAI 1 Antibodies

Santa Cruz Biotechnology features a diverse variety of KAI 1 monoclonal antibodies for research in understanding KAI 1's role in various biological processes. KAI 1 monoclonal antibodies are suitable for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KAI 1, also known as KAI1/CD82 protein, is a member of the tetraspanin family and plays a crucial role in cell adhesion, migration, and signaling. Research has shown KAI 1's involvement in tumor suppression and its association with metastasis regulation in various cancers. Understanding KAI 1 function is essential for exploring its potential as a therapeutic target in cancer treatment. Researchers worldwide utilize KAI 1 monoclonal antibodies to investigate cellular mechanisms and pathways influenced by KAI 1. Current studies focus on how KAI 1 interacts with other proteins to regulate cell behavior and cancer progression. Ongoing research with KAI 1 monoclonal antibodies continues to reveal new insights about cancer development and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of KAI 1's role in cancer biology and therapeutic development.